Evidence map›Paper›PMID 31920468›Full record

ArticleContrast media & molecular imaging2019

Assessment of the Relaxation-Enhancing Properties of a Nitroxide-Based Contrast Agent TEEPO-Glc with

Maiju Soikkeli, Mikko I Kettunen, Riikka Nivajärvi, Venla Olsson, Seppo Rönkkö, Johanna P Laakkonen, Vesa-Pekka Lehto, Jari Kavakka, Sami Heikkinen

Abstract read
In one paragraph

Article in Contrast media & molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. 3,4-Unsubstituted 2-Molecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maiju SoikkeliDepartment of Chemistry, University of Helsinki, FI-00014 Helsinki, Finland.ORCID 0000-0002-9328-1774
Mikko I KettunenA. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, FI-70211 Kuopio, Finland.ORCID 0000-0002-2004-660X
Riikka NivajärviA. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, FI-70211 Kuopio, Finland.
Venla OlssonA. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, FI-70211 Kuopio, Finland.
Seppo RönkköDepartment of Applied Physics, University of Eastern Finland, FI-70211 Kuopio, Finland.
Johanna P LaakkonenA. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, FI-70211 Kuopio, Finland.
Vesa-Pekka LehtoDepartment of Applied Physics, University of Eastern Finland, FI-70211 Kuopio, Finland.ORCID 0000-0001-8153-1070
Jari KavakkaDepartment of Chemistry, University of Helsinki, FI-00014 Helsinki, Finland.
Sami HeikkinenDepartment of Chemistry, University of Helsinki, FI-00014 Helsinki, Finland.ORCID 0000-0002-1892-8574

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic resonance imaging examinations are frequently carried out using contrast agents to improve the image quality. Practically all clinically used contrast agents are based on paramagnetic metals and lack in selectivity and specificity. A group of stable organic radicals, nitroxides, has raised interest as new metal-free contrast agents for MRI. Their structures can easily be modified to incorporate different functionalities. In the present study, a stable nitroxide TEEPO (2,2,6,6-tetraethylpiperidin-1-oxyl) was linked to a glucose moiety (Glc) to construct a water-soluble, potentially tumor-targeting compound with contrast-enhancing ability. The ability was assessed with

Indexed as

AnimalsContrast MediaCyclic N-OxidesElectron Spin Resonance SpectroscopyHeLa CellsHumansMagnetic Resonance ImagingNeoplasmsPiperidinesRatsSpin Labels2,2,6,6-tetraethylpiperidine nitroxideContrast MediaCyclic N-OxidesPiperidinesSpin Labels

Identifiers

PMID31920468
PMCPMC6942761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.